Miki K - Search Results

1

Correlation of serum pepsinogens and gross appearances combined with histology in early gastric cancer.

Fujishiro M, Oka M, Yahagi N, Nakamura M, Kakushima N, Kodashima S, Kobayashi K, Hashimoto T, Yamamichi N, Moriyama Y, Tateishi A, Ono S, Shimizu Y, Ichinose M, Miki K, Omata M. Fujishiro M, et al. Among authors: miki k. J Exp Clin Cancer Res. 2006 Jun;25(2):207-12. J Exp Clin Cancer Res. 2006. PMID: 16918132

2

Long-term results of gastric cancer screening using the serum pepsinogen test method among an asymptomatic middle-aged Japanese population.

Miki K, Fujishiro M, Kodashima S, Yahagi N. Miki K, et al. Dig Endosc. 2009 Apr;21(2):78-81. doi: 10.1111/j.1443-1661.2009.00839.x. Dig Endosc. 2009. PMID: 19691778

3

Gastric cancer screening of a high-risk population in Japan using serum pepsinogen and barium digital radiography.

Ohata H, Oka M, Yanaoka K, Shimizu Y, Mukoubayashi C, Mugitani K, Iwane M, Nakamura H, Tamai H, Arii K, Nakata H, Yoshimura N, Takeshita T, Miki K, Mohara O, Ichinose M. Ohata H, et al. Among authors: miki k. Cancer Sci. 2005 Oct;96(10):713-20. doi: 10.1111/j.1349-7006.2005.00098.x. Cancer Sci. 2005. PMID: 16232204 Free PMC article. Clinical Trial.

4

Clinical application of serum pepsinogen I and II levels for mass screening to detect gastric cancer.

Miki K, Ichinose M, Ishikawa KB, Yahagi N, Matsushima M, Kakei N, Tsukada S, Kido M, Ishihama S, Shimizu Y, et al. Miki K, et al. Jpn J Cancer Res. 1993 Oct;84(10):1086-90. doi: 10.1111/j.1349-7006.1993.tb02805.x. Jpn J Cancer Res. 1993. PMID: 8226283 Free PMC article.

5

A minute gastric cancer detected by a new screening method using serum pepsinogen I and II.

Yahagi N, Miki K, Ichinose M, Kakei N, Matsushima M, Kido M, Shimizu Y, Ishihama S, Tsukada S, Kurokawa K, et al. Yahagi N, et al. Among authors: miki k. Adv Exp Med Biol. 1995;362:145-8. doi: 10.1007/978-1-4615-1871-6_18. Adv Exp Med Biol. 1995. PMID: 8540313 No abstract available.

6

Two cases of early colorectal cancer associated with gastric adenoma detected by serum pepsinogen screening method.

Shimizu Y, Kakei N, Wada T, Yahagi N, Kido M, Ishihama S, Tsukada S, Matsushima M, Ichinose M, Miki K, et al. Shimizu Y, et al. Among authors: miki k. Adv Exp Med Biol. 1995;362:149-54. doi: 10.1007/978-1-4615-1871-6_19. Adv Exp Med Biol. 1995. PMID: 8540314 No abstract available.

7

Enzyme-linked immunosorbent assays for serum pepsinogens I and II using monoclonal antibodies--with data on peptic ulcer and gastric cancer.

Huang SC, Miki K, Furihata C, Ichinose M, Shimizu A, Oka H. Huang SC, et al. Among authors: miki k. Clin Chim Acta. 1988 Jun 30;175(1):37-50. doi: 10.1016/0009-8981(88)90033-2. Clin Chim Acta. 1988. PMID: 3168282

8

[Serum pepsinogen I level in patients with stomach cancer--its value and limitation in clinical use].

Miki K, Ichinose M. Miki K, et al. Gan To Kagaku Ryoho. 1989 Apr;16(4 Pt 2-1):1122-8. Gan To Kagaku Ryoho. 1989. PMID: 2730017 Japanese.

9

The clinical application of the serum pepsinogen I and II levels as a mass screening method for gastric cancer.

Miki K, Ichinose M, Kakei N, Yahagi N, Matsushima M, Tsukada S, Ishihama S, Shimizu Y, Suzuki T, Kurokawa K, et al. Miki K, et al. Adv Exp Med Biol. 1995;362:139-43. doi: 10.1007/978-1-4615-1871-6_17. Adv Exp Med Biol. 1995. PMID: 8540312 No abstract available.

10

Differentially expressed MHC class II-associated invariant chain in rat stomach pyloric mucosa with N-methyl-N-nitro-nitrosoguanidine exposure.

Furihata C, Oka M, Yamamoto M, Ito T, Ichinose M, Miki K, Tatematsu M, Sakaki Y, Reske K. Furihata C, et al. Among authors: miki k. Cancer Res. 1997 Apr 15;57(8):1416-8. Cancer Res. 1997. PMID: 9108437

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,667 results

Search Page

Filters